CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Taigen Biopharmaceuticals Holdings Ltd Company Snapshot
Taigen Biopharmaceuticals Holdings Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Taigen Biopharmaceuticals Holdings Ltd with three other companies in this sector in Taiwan: Genomics Biosci &Tech Co Ltd (2017 sales of 439.53 million Taiwanese Dollars [US$14.28 million] ), Medigen Biotechnology Corporation (457.78 million Taiwanese Dollars [US$14.87 million] of which 78% was Drug Discovery), and Sofiva Genomics Co Ltd (423.94 million Taiwanese Dollars [US$13.77 million] ).

Sales Analysis. Sales increased substantially in 2017: Taigen Biopharmaceuticals Holdings Ltd reported sales of 553.21 million Taiwanese Dollars (US$17.97 million) for the year ending December of 2017. This represents an increase of 278.9% versus 2016, when the company's sales were 146.02 million Taiwanese Dollars. Sales of Medical Development saw an increase of 318.8% in 2017, from 131.49 million Taiwanese Dollars to 550.66 million Taiwanese Dollars. Not all segments of Taigen Biopharmaceuticals Holdings Ltd experienced an increase in sales in 2017: sales of Medical Consultance fell 82.5% to 2.55 million Taiwanese Dollars.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Taigen Biopharmaceuticals Holdings Ltd
  Stock Performance Chart for Taigen Biopharmaceuticals Holdings Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 16.65
(Figures in Taiwanese Dollars)
1 Week 2.8%   13 Weeks 0.6%  
4 Weeks -20.1%   52 Weeks -21.8%  
 
Taigen Biopharmaceuticals Holdings Ltd Key Data:
  Ticker: 4157 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 553,208,000
(Year Ending Jan 2018).
Employees: N/A
  Currency: Taiwanese Dollars Market Cap: 11,934,054,000
  Fiscal Yr Ends: December Shares Outstanding: 716,760,000
  Share Type: Ordinary Closely Held Shares: 358,613,000
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.